ROVUS Asia Registry (Evaluate Safety and Effectiveness of Rotational Atherectomy and Intravascular Ultrasound for Heavily Calcified Coronary Lesion)
ROVUS
1 other identifier
observational
1,000
2 countries
2
Brief Summary
Rotablation with or without other calcium debulking therapies is a safe adjunctive procedure for patients with severe coronary calcification requiring Percutaneous Coronary Intervention (PCI).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2021
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 2, 2021
CompletedFirst Posted
Study publicly available on registry
February 8, 2021
CompletedStudy Start
First participant enrolled
March 10, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 29, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
ExpectedApril 23, 2021
April 1, 2021
3 years
February 2, 2021
April 21, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Primary efficacy endpoint (Procedural success)
Procedural success defined as \< 20% residual stenosis in treated segment without on-table mortality with TIMI 3 flow.
Duration of procedure
Secondary Outcomes (5)
Death
1 year
Periprocedural myocardial infarction (MI)
within 48 hours of procedure
Complications
within 48 hours of procedure
Complication
within 48 hours of procedure
Procedural time
Duration of procedure
Study Arms (2)
Eligible subjects who underwent RA prior to PCI (with informed consent taken to join the study)
Informed consent to be obtained either prior to PCI with rotational atherectomy planned or within 48 hours after rotational atherectomy. There will be data collection of history/demographics, laboratory results, symptoms, any serious adverse events recording for this cohort as well as a telephone follow up at 12months post rotational atherectomy.
Eligible subjects who underwent RA prior to PCI (without informed consent taken to join the study)
Subjects that were demised or refused to give consent will fall under this cohort. The data collection of this cohort will be done through screening of in-hospital data via available local PCI database/registry.
Interventions
Rotational atherectomy (RA) has been the most used atherectomy modality since its first inception in1988. RA uses high speed rotation (140,000 - 180,000 rpm) to ablate inelastic plaque, resulting in debris averaging 5µm in size24. The main focus of RA in the era of DES stent has been on plaque modification rather that plaque debulking with more papers showing improved PCI success rates.
Eligibility Criteria
All patients with signed informed consent for percutaneous coronary intervention (PCI) and are eligible for calcium debulking treatment with rotational atherectomy with or without other forms of calcium debulking therapies will be enrolled into this study.
You may qualify if:
- Able to understand and sign an informed consent form
- Presence of clinical indication for percutaneous coronary intervention (PCI) and/or stent placement
- Subjects willing to comply with all research and follow-up requirements.
- Angiographic criteria (ONE of the following criteria MUST be met)
- Target lesions visually have at least moderate calcifications\*
- Target lesion balloon dilatation failure
- Inability of devices (microcatheters, balloons or stents) to pass through the target lesion.
- Procedural criteria
- All patients treated with RA with or without other forms of debulking therapy
- Moderate calcification is defined as radio-opacities noted only during cardiac cycle prior to contrast injection whereas severe calcification is defined as radio-opacities seen without cardiac motion prior to contrast injection, usually affecting both sides of the arterial lumen.
You may not qualify if:
- Decline to give consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- National Heart Centre Singaporelead
- Boston Scientific Corporationcollaborator
Study Sites (2)
Kokura Memorial hospital
Kitakyushu, 802-8555, Japan
National Heart Centre Singapore
Singapore, 169609, Singapore
Related Publications (2)
Lee MS, Park KW, Shlofmitz E, Shlofmitz RA. Comparison of Rotational Atherectomy Versus Orbital Atherectomy for the Treatment of Heavily Calcified Coronary Plaques. Am J Cardiol. 2017 May 1;119(9):1320-1323. doi: 10.1016/j.amjcard.2017.01.025. Epub 2017 Feb 10.
PMID: 28258729BACKGROUNDSharma SK, Tomey MI, Teirstein PS, Kini AS, Reitman AB, Lee AC, Genereux P, Chambers JW, Grines CL, Himmelstein SI, Thompson CA, Meredith IT, Bhave A, Moses JW. North American Expert Review of Rotational Atherectomy. Circ Cardiovasc Interv. 2019 May;12(5):e007448. doi: 10.1161/CIRCINTERVENTIONS.118.007448.
PMID: 31084239BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Khung Keong Yeo
Singhealth Foundation
- PRINCIPAL INVESTIGATOR
Shoichi Kuramitsu
Kokura Memorial Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 2, 2021
First Posted
February 8, 2021
Study Start
March 10, 2021
Primary Completion
February 29, 2024
Study Completion (Estimated)
December 31, 2026
Last Updated
April 23, 2021
Record last verified: 2021-04
Data Sharing
- IPD Sharing
- Will not share